Targinta AB
Developing targeted antibodies and ADCs for aggressive cancers.
Overview
- 0
- Employees
- ≤1K SEK
- Revenue
- 2018
- Founded
Key Decision Makers
Evy Lundgren-Åkerlund
CSO
Description
Targinta AB is a Swedish biotechnology company focused on developing novel treatments for aggressive and life-threatening cancers. The company specializes in creating targeted, toxin-armed antibodies, known as Antibody-Drug Conjugates (ADCs), and functional blocking antibodies. Their entire product...